Altıntaş, Y.E.; Kınıkoğlu, O.; Yıldız, A.; Işık, D.; Özkerim, U.; Öksüz, S.; Tüylü, T.B.; Sürmeli, H.; Turan, N.; Odabaş, H.
Trastuzumab Rechallenge in HER2-Positive Metastatic Breast Cancer: A Promising Strategy for Enhanced Progression-Free Survival Post Ado-Trastuzumab Emtansine Progression. Medicina 2024, 60, 2069.
https://doi.org/10.3390/medicina60122069
AMA Style
Altıntaş YE, Kınıkoğlu O, Yıldız A, Işık D, Özkerim U, Öksüz S, Tüylü TB, Sürmeli H, Turan N, Odabaş H.
Trastuzumab Rechallenge in HER2-Positive Metastatic Breast Cancer: A Promising Strategy for Enhanced Progression-Free Survival Post Ado-Trastuzumab Emtansine Progression. Medicina. 2024; 60(12):2069.
https://doi.org/10.3390/medicina60122069
Chicago/Turabian Style
Altıntaş, Yunus Emre, Oğuzcan Kınıkoğlu, Anıl Yıldız, Deniz Işık, Uğur Özkerim, Sıla Öksüz, Tuğba Başoğlu Tüylü, Heves Sürmeli, Nedim Turan, and Hatice Odabaş.
2024. "Trastuzumab Rechallenge in HER2-Positive Metastatic Breast Cancer: A Promising Strategy for Enhanced Progression-Free Survival Post Ado-Trastuzumab Emtansine Progression" Medicina 60, no. 12: 2069.
https://doi.org/10.3390/medicina60122069
APA Style
Altıntaş, Y. E., Kınıkoğlu, O., Yıldız, A., Işık, D., Özkerim, U., Öksüz, S., Tüylü, T. B., Sürmeli, H., Turan, N., & Odabaş, H.
(2024). Trastuzumab Rechallenge in HER2-Positive Metastatic Breast Cancer: A Promising Strategy for Enhanced Progression-Free Survival Post Ado-Trastuzumab Emtansine Progression. Medicina, 60(12), 2069.
https://doi.org/10.3390/medicina60122069
